← FDA Drug Approvals (Drugs@FDA)

IDARUBICIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2002-05-01

Drug application

FDA Application #

ANDA065037

Application type

Abbreviated New Drug Application (Generic)

Brand name

IDARUBICIN HYDROCHLORIDE

Generic name

Idarubicin Hydrochloride

Active ingredients

IDARUBICIN HYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

2002-05-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown